Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients-Reference-Cited by-同舟云学术

Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients

Published:2015 Issue:1 Volume:5 Page:165-174
ISSN:1877-718X
Container-title:Journal of Parkinson's Disease
language:
Short-container-title:

Author:

Slevin John T.¹,Fernandez Hubert H.²,Zadikoff Cindy³,Hall Coleen⁴,Eaton Susan⁴,Dubow Jordan⁴,Chatamra Krai⁴,Benesh Janet⁴

Affiliation:

1. University of Kentucky Medical Center, Lexington, KY, USA

2. Cleveland Clinic, Cleveland, OH, USA

3. Northwestern University Feinberg School of Medicine, Chicago, IL, USA

4. AbbVie Inc., North Chicago, IL, USA

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Clinical Neurology

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion;Movement Disorders Clinical Practice;2024-06-24

2. An Artificial Neural Network Predicts Gender Differences of Motor and Non-Motor Symptoms of Patients with Advanced Parkinson’s Disease under Levodopa–Carbidopa Intestinal Gel;Medicina;2024-05-26

3. Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study;Neurology and Therapy;2024-02-12

4. Levodopa-carbidopa intestinal gel infusion in Parkinson's disease;International Review of Movement Disorders;2024

5. Cost‐Effectiveness of Carbidopa‐Levodopa Enteral Suspension for Advanced Parkinson's Disease in the United States;Movement Disorders;2023-10-25